Compare AU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AU | BIO |
|---|---|---|
| Founded | 1944 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 8.7B |
| IPO Year | 1972 | N/A |
| Metric | AU | BIO |
|---|---|---|
| Price | $91.11 | $319.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $82.67 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.3M | 169.4K |
| Earning Date | 02-18-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ 237.48 | N/A |
| EPS | ★ 4.53 | N/A |
| Revenue | ★ $8,575,000,000.00 | $2,557,500,000.00 |
| Revenue This Year | $71.69 | $1.62 |
| Revenue Next Year | $14.39 | $2.26 |
| P/E Ratio | $20.48 | ★ N/A |
| Revenue Growth | ★ 61.82 | N/A |
| 52 Week Low | $24.24 | $211.43 |
| 52 Week High | $93.85 | $373.69 |
| Indicator | AU | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 57.57 |
| Support Level | $82.94 | $300.26 |
| Resistance Level | $93.85 | $328.25 |
| Average True Range (ATR) | 2.73 | 7.26 |
| MACD | 0.19 | 2.52 |
| Stochastic Oscillator | 74.06 | 71.96 |
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.